Mor G - Search Results

1

Identification of differentially expressed genes in clinically distinct groups of serous ovarian carcinomas using cDNA microarray.

Collins Y, Tan DF, Pejovic T, Mor G, Qian F, Rutherford T, Varma R, McQuaid D, Driscoll D, Jiang M, Deeb G, Lele S, Nowak N, Odunsi K. Collins Y, et al. Among authors: mor g. Int J Mol Med. 2004 Jul;14(1):43-53. Int J Mol Med. 2004. PMID: 15202015

2

Absence of estrogen receptor-beta expression in metastatic ovarian cancer.

Rutherford T, Brown WD, Sapi E, Aschkenazi S, Muñoz A, Mor G. Rutherford T, et al. Among authors: mor g. Obstet Gynecol. 2000 Sep;96(3):417-21. doi: 10.1016/s0029-7844(00)00917-0. Obstet Gynecol. 2000. PMID: 10960636 Free article.

3

Hormonal regulation of apoptosis and the Fas and Fas ligand system in human endometrial cells.

Song J, Rutherford T, Naftolin F, Brown S, Mor G. Song J, et al. Among authors: mor g. Mol Hum Reprod. 2002 May;8(5):447-55. doi: 10.1093/molehr/8.5.447. Mol Hum Reprod. 2002. PMID: 11994542

4

Epithelial ovarian cancer cells secrete functional Fas ligand.

Abrahams VM, Straszewski SL, Kamsteeg M, Hanczaruk B, Schwartz PE, Rutherford TJ, Mor G. Abrahams VM, et al. Among authors: mor g. Cancer Res. 2003 Sep 1;63(17):5573-81. Cancer Res. 2003. PMID: 14500397

5

Serum protein markers for early detection of ovarian cancer.

Mor G, Visintin I, Lai Y, Zhao H, Schwartz P, Rutherford T, Yue L, Bray-Ward P, Ward DC. Mor G, et al. Proc Natl Acad Sci U S A. 2005 May 24;102(21):7677-82. doi: 10.1073/pnas.0502178102. Epub 2005 May 12. Proc Natl Acad Sci U S A. 2005. PMID: 15890779 Free PMC article.

6

Carcinosarcoma of the ovary.

Silasi DA, Illuzzi JL, Kelly MG, Rutherford TJ, Mor G, Azodi M, Schwartz PE. Silasi DA, et al. Among authors: mor g. Int J Gynecol Cancer. 2008 Jan-Feb;18(1):22-9. doi: 10.1111/j.1525-1438.2007.00948.x. Epub 2007 Apr 19. Int J Gynecol Cancer. 2008. PMID: 17451459

7

MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer.

Silasi DA, Alvero AB, Illuzzi J, Kelly M, Chen R, Fu HH, Schwartz P, Rutherford T, Azodi M, Mor G. Silasi DA, et al. Among authors: mor g. Yale J Biol Med. 2006 Dec;79(3-4):153-63. Yale J Biol Med. 2006. PMID: 17940625 Free PMC article.

8

Phenoxodiol: pharmacology and clinical experience in cancer monotherapy and in combination with chemotherapeutic drugs.

Silasi DA, Alvero AB, Rutherford TJ, Brown D, Mor G. Silasi DA, et al. Among authors: mor g. Expert Opin Pharmacother. 2009 Apr;10(6):1059-67. doi: 10.1517/14656560902837980. Expert Opin Pharmacother. 2009. PMID: 19364253 Review.

9

Phase II evaluation of phenoxodiol in combination with cisplatin or paclitaxel in women with platinum/taxane-refractory/resistant epithelial ovarian, fallopian tube, or primary peritoneal cancers.

Kelly MG, Mor G, Husband A, O'Malley DM, Baker L, Azodi M, Schwartz PE, Rutherford TJ. Kelly MG, et al. Among authors: mor g. Int J Gynecol Cancer. 2011 May;21(4):633-9. doi: 10.1097/IGC.0b013e3182126f05. Int J Gynecol Cancer. 2011. PMID: 21412168 Clinical Trial.

10

Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer.

Steffensen KD, Alvero AB, Yang Y, Waldstrøm M, Hui P, Holmberg JC, Silasi DA, Jakobsen A, Rutherford T, Mor G. Steffensen KD, et al. Among authors: mor g. J Oncol. 2011;2011:620523. doi: 10.1155/2011/620523. Epub 2011 Aug 29. J Oncol. 2011. PMID: 21904548 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

388 results

Search Page

Filters